In lymphatic vasculature of the TME, MHC-I expression and tumor antigen display capacity paired with reduced co-stimulatory machinery and PD-L1 expression induces tolerance by CD8+ T cells making contact with tumor lymphatic vasculature (53, 54). Here, CD8A is linked to neoplasm.